These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 31560743

  • 21. Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor-α inhibitors.
    Balaguer-Franch I, Hernández de la Torre-Ruiz E, Lacasta-Plasin C, García-Piqueras P, Menchén-Viso L, Baniandrés-Rodríguez O.
    Clin Exp Dermatol; 2022 Feb; 47(2):453-455. PubMed ID: 34431537
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F, Portela F.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():3-14. PubMed ID: 21175228
    [Abstract] [Full Text] [Related]

  • 26. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M.
    Z Gastroenterol; 2003 Jan 14; 41(1):11-7. PubMed ID: 12541166
    [Abstract] [Full Text] [Related]

  • 27. Atypical Orofacial Granulomatosis Associated With Bowel Relapse in an Adult With Crohn's Disease Under Anti-TNF Therapy.
    Moghadam P, Dumas M, Blum L, Gimenez I, Hervio P, Begon E.
    Inflamm Bowel Dis; 2022 Feb 01; 28(2):e25-e26. PubMed ID: 34569594
    [No Abstract] [Full Text] [Related]

  • 28. Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery.
    Dai C, Huang YH.
    Dig Dis Sci; 2022 Apr 01; 67(4):1421-1422. PubMed ID: 33939139
    [No Abstract] [Full Text] [Related]

  • 29. [Cerebral vasculitis: A rare complication of pneumococcal meningitis].
    Regaieg K, Baccouche N, Souissi B, Bahloul M, Bouaziz M.
    Med Mal Infect; 2016 May 01; 46(3):170-1. PubMed ID: 26867663
    [No Abstract] [Full Text] [Related]

  • 30. Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.
    van Balkom BP, Schoon EJ, Stockbrügger RW, Wolters FL, van Hogezand RA, van Deventer SJ, Oldenburg B, van Dullemen HM, Russel MG.
    Aliment Pharmacol Ther; 2002 Jun 01; 16(6):1101-7. PubMed ID: 12030951
    [Abstract] [Full Text] [Related]

  • 31. Fatal course of cerebral vasculitis induced by neuroborreliosis.
    Buchwald F, Abul-Kasim K, Tham J, Hansen BU.
    Neurol India; 2010 Jun 01; 58(1):139-41. PubMed ID: 20228487
    [No Abstract] [Full Text] [Related]

  • 32. Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.
    Inokuchi T, Takahashi S, Hiraoka S, Toyokawa T, Takagi S, Takemoto K, Miyaike J, Fujimoto T, Higashi R, Morito Y, Nawa T, Suzuki S, Nishimura M, Inoue M, Kato J, Okada H.
    J Gastroenterol Hepatol; 2019 Aug 01; 34(8):1329-1336. PubMed ID: 30724387
    [Abstract] [Full Text] [Related]

  • 33. Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.
    Gekka M, Sugiyama T, Nomura M, Kato Y, Nishihara H, Asaoka K.
    BMC Neurol; 2015 Sep 21; 15():169. PubMed ID: 26390922
    [Abstract] [Full Text] [Related]

  • 34. [Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication].
    Lee KM, Kim JS, Shin DH, Cheong JY, Yoo BM, Kim JK, Lee KJ, Hahm KB, Kim JH, Cho SW.
    Korean J Gastroenterol; 2004 Nov 21; 44(5):259-66. PubMed ID: 15564805
    [Abstract] [Full Text] [Related]

  • 35. Life-threatening disseminated tuberculosis as a complication of treatment by infliximab for Crohn's disease: report of two cases, including cerebral tuberculomas and miliary tuberculosis.
    Tissot C, Couraud S, Meng L, Girard P, Avrillon V, Gérinière L, Perrot E, Souquet PJ.
    J Crohns Colitis; 2012 Oct 21; 6(9):946-9. PubMed ID: 22749231
    [Abstract] [Full Text] [Related]

  • 36. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R, Ferrer Ríos T, Gallego Gallegos R, Ramos Lora M, Ynfante Ferrús M, Figueruela López B.
    Rev Esp Enferm Dig; 2006 Jan 21; 98(1):60-1. PubMed ID: 16555939
    [No Abstract] [Full Text] [Related]

  • 37. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C, Calado J, Cravo M.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():15-7. PubMed ID: 21175229
    [Abstract] [Full Text] [Related]

  • 38. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab.
    Korzenik JR.
    Gastroenterol Clin North Am; 2004 Jun 14; 33(2):285-301, ix. PubMed ID: 15177539
    [Abstract] [Full Text] [Related]

  • 39. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.
    Thomas CW, Weinshenker BG, Sandborn WJ.
    Inflamm Bowel Dis; 2004 Jan 14; 10(1):28-31. PubMed ID: 15058523
    [Abstract] [Full Text] [Related]

  • 40. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.
    Scand J Gastroenterol; 2006 Sep 14; 41(9):1064-72. PubMed ID: 16938720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.